Alphatec Spine Reports $44M in Total Revenue, 49% Increase. The company reported $30 million in U.S. revenues, an increase of 15.2 percent from the third quarter of 2009. The gross profit for the third quarter was reported as $28.9 million, a 44.1 percent increase over the third quarter of 2009. Dirk Kuyper, Alphatec Spine’s president and CEO, attributed the company’s success to the launch of several new products during the third quarter.
Read more of “Alphatec Spine Reports $44M in Total Revenue, 49% Increase.”
ArthroCare Reports $87.9M in Total Revenue, 10.6% Increase. The product sales in ArthroCare’s sports medicine division were reported as $6.4 million, a 12.6 percent increase from the third quarter of 2009. Sales of spine products declined during the third quarter of 2010. A decline in American sales was off-set by increased international product sales.
Read more of “ArthroCare Reports $87.9M in Total Revenue, 10.6% Increase.”
Biomet Reports $641M in Net Sales, 2% Increase. The company reported a 3 percent and 7 percent increase in orthopedic reconstructive sales in the world and U.S., respectively during the first quarter of 2011. Knee sales increased by 4 percent, extremity sales increased by 25 percent, and sports medicine sales grew by 15 percent worldwide.
Read more of “Biomet Reports $641M in Net Sales, 2% Increase.”
DJO Reports $233.6M in Net Sales. The company’s net sales decreased from $236.2 million reported during the third quarter of 2009. The company experienced a net loss of $7.7 million, a decrease from last year’s third quarter loss of $11.4 million. The net loss is attributable to non-recurring integration charges and ongoing restructuring and acquisitions.
Read more of “DJO Reports $233.6M in Net Sales.”
Integra LifeSciences Reports $186.6M in Total Revenue, 8.3% Increase. Integra’s orthopedic business has earned $72,970 during the third quarter, a 13.8 percent increase over last year. The company’s neurosurgery business also experienced a 3.8 percent increase to $69,816. The company reported a GAAP net income of $16.5 million, an increase from the third quarter of 2009.
Read more of “Integra LifeSciences reports $186.6M in Total Revenue, 8.3% Increase.”
Johnson & Johnson Reports $15B in Net Sales, 0.7% Decrease. The company counted DePuy’s orthopedic joint reconstruction business among the contributors to the company’s operational growth, despite the recall of the ASR hip replacement. During this quarter, the company also filed a biologics license application in the U.S. to expand the SIMPONI label in rheumatoid arthritis to include inhibiting the progression of structural damage.
Read more of “Johnson & Johnson Reports $15B in Net Sales, .07% Decrease.”
Medtronic Reports $3.903B in Total Revenue, 2% Increase. The international revenue was reported as $1.608 billion, a 4 percent increase over the second quarter of last year, and accounted for 41 percent of Medtronic’s worldwide revenue. Spinal revenue was reported as $850 million, a decrease of 1 percent from the second quarter of last year.
Read more of “Medtronic Reports $3.903B in Total Revenue, 2% Increase.”
NeoStem Reports $51.7M in Total Revenues. The revenues were increased from the third quarter of 2009. The company reported net cash used in operating activities at the nine months end of 2010 as $3.2 million, a decrease from the $9.5 million reported for the same period in 2009. NeoStem invested $12.5 million in capital expenditures related to continuing expansion in the Chinese market.
Read more of “NeoStem Reports $51.7M in 3Q Total Revenues.”
Orthofix Reports $138.9M in Total Revenue, 3% Increase. Orthofix’s orthopedic business reported $34 million in revenue for the third quarter, which was a 2 percent increase from last year. Sports medicine revenue experienced a 4 percent decrease from last year, which can be attributed to a revenue recognition change from one distributor resulting in a commission expense.
Read more of “Othofix Reports $138.9M in Total Revenue, 3% Increase.”
Stryker Reports $1.768B in Net Sales, 1.3% Increase. The growth was larger than expected, said Stryker President and CEO Stephen P. MacMillan. The growth could be attributed to the 16.1 percent increase in worldwide sales of MedSurg Equipment. International sales were $594 million, a 1.7 percent increase over last year. Worldwide sales of orthopedic implants were $1.029 billion, an increase of 1.2 percent.
Read more of “Stryker Reports $1.768B in Net Sales, 1.3% Increase.”
Synthes Reports $907.2M in Net Sales, 4.5% Increase. The increase is partially attributed to a 2.1 percent increase in the North American sales from the third quarter of 2009. European sales decreased from $198.6 million during the third quarter of 2009 to $196.5 million during the third quarter of 2010. While Synthes performed well in the trauma market with products such as the Variable Angle LCP and the MatrixMIDFACE, the company struggled with the launch of “Matrix Spine” and targeted competitive conversion initiatives.
Read more of “Synthes Reports $907.2M in Net Sales, 4.5% Increase.”
Zimmer Holdings Reports $965M in Net Sales, 1.1% Decrease. David Dvorak, Zimmer president and CEO, attributed the decrease to the “challenging global economic conditions.” Adjusted net earnings were reported as $192.4 million, a 2.2 percent increase over the third quarter of 2009. During this quarter, Zimmer used $225.6 million to acquire 4.2 million shares.
Read more of “Zimmer Holdings Reports $965M in Net Sales, 1.1% Decrease.”
